Page last updated: 2024-10-31

mitoxantrone and Degenerative Diseases, Central Nervous System

mitoxantrone has been researched along with Degenerative Diseases, Central Nervous System in 1 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research Excerpts

ExcerptRelevanceReference
" Pediatric Multiple Sclerosis seems to respond better to immunosuppressant agents (Mitoxantrone, Cyclophosphamide, Natalizumab), as well as Neuromyelitis optica (Rituximab, Mycofenolate)."4.91The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. ( Cocuzza, S; Di Mauro, P; Falsaperla, R; Ledda, C; Lubrano, R; Matin, N; Pavone, P; Serra, A; Tabatabaie, O; Vitaliti, G, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vitaliti, G1
Tabatabaie, O1
Matin, N1
Ledda, C1
Pavone, P1
Lubrano, R1
Serra, A1
Di Mauro, P1
Cocuzza, S1
Falsaperla, R1

Reviews

1 review available for mitoxantrone and Degenerative Diseases, Central Nervous System

ArticleYear
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.
    Human vaccines & immunotherapeutics, 2015, Volume: 11, Issue:12

    Topics: Autoimmune Diseases; Child; Chorea; Cyclophosphamide; Guillain-Barre Syndrome; Humans; Immunoglobuli

2015